Insights

Innovative Vaccine Platform Vaxart's proprietary oral vaccine platform offers a unique delivery method targeting mucosal immunity, presenting opportunities to collaborate with healthcare providers and pharmaceutical companies seeking next-generation immunization solutions.

Expanding Disease Portfolio With development underway for vaccines against COVID-19, Norovirus, Influenza, and HPV, Vaxart demonstrates a robust pipeline that can address various healthcare needs, opening avenues for partnership in vaccine distribution and licensing.

Clinical Progress & Trials Participation in Phase II trials highlights Vaxart’s progress in clinical development, providing opportunities to support trial-related services, clinical supplies, and potential co-marketing collaborations once products reach approval stages.

Engagement in Industry Events Active participation in global bioinnovation forums and investment conferences indicates a focus on building strategic alliances, making it a promising partner for investors and organizations interested in cutting-edge biotech innovations.

Financial and Leadership Growth Recent leadership appointments and ongoing funding initiatives suggest a growing infrastructure and strategic expansion potential, making Vaxart an attractive partner for investment, joint ventures, or strategic alliances in biotech development.

Similar companies to Vaxart, Inc.

Vaxart, Inc. Tech Stack

Vaxart, Inc. uses 8 technology products and services including oEmbed, JSON-LD, DataTables, and more. Explore Vaxart, Inc.'s tech stack below.

oEmbed
Dev Tools
JSON-LD
Javascript Frameworks
DataTables
Javascript Libraries
New Relic
Real User Monitoring
Yoast SEO
Search Engines
X-XSS-Protection
Security
Cloudflare Bot Management
Security
X-Content-Type-Options
Web & Portal Technology

Media & News

Vaxart, Inc.'s Email Address Formats

Vaxart, Inc. uses at least 1 format(s):

Vaxart, Inc. Email Formats	Example	Percentage
FLast@vaxart.com	JDoe@vaxart.com	99%
FMiddleLast@vaxart.com	JMichaelDoe@vaxart.com	1%

Frequently Asked Questions

Where is Vaxart, Inc.'s headquarters located?

Vaxart, Inc.'s main headquarters is located at 290 Utah Avenue South San Francisco, California 94080 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Vaxart, Inc.'s phone number?

You can contact Vaxart, Inc.'s main corporate office by phone at

+1-650-550-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Vaxart, Inc.'s stock symbol?

Vaxart, Inc. is a publicly traded company; the company's stock symbol is VXRT.

What is Vaxart, Inc.'s official website and social media links?

Vaxart, Inc.'s official website is vaxart.com and has social profiles on LinkedIn Crunchbase.

What is Vaxart, Inc.'s SIC code NAICS code?

Vaxart, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Vaxart, Inc. have currently?

As of April 2026, Vaxart, Inc. has approximately 106 employees across 2 continents, including North AmericaEurope. Key team members include Chief Financial Officer Executive Vice President: M. C.Chief Financial Officer: J. G.Chief Financial Officer: J. H.. Explore Vaxart, Inc.'s employee directory with LeadIQ.

What industry does Vaxart, Inc. belong to?

Vaxart, Inc. operates in the Biotechnology Research industry.

What technology does Vaxart, Inc. use?

Vaxart, Inc.'s tech stack includes oEmbedJSON-LDDataTablesNew RelicYoast SEOX-XSS-ProtectionCloudflare Bot ManagementX-Content-Type-Options.

What is Vaxart, Inc.'s email format?

Vaxart, Inc.'s email format typically follows the pattern of FLast@vaxart.com. Find more Vaxart, Inc. email formats with LeadIQ.

When was Vaxart, Inc. founded?

Vaxart, Inc. was founded in 2004.

Vaxart, Inc.

Q: What is Vaxart, Inc.'s official website and social media links?

Vaxart, Inc.'s official website is vaxart.com. Vaxart, Inc. has social profiles on LinkedIn.

Q: How many employees does Vaxart, Inc. have currently?

Vaxart, Inc. has approximately 106 employees.

Q: What technology does Vaxart, Inc. use?

Vaxart, Inc.'s tech stack includes Drupal Multisite, WP Engine, Astra, Cloudinary, MySQL.

Q: What is Vaxart, Inc.'s NAICS code?

Vaxart, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCalifornia, United States51-200 Employees

For two hundred years vaccines have been administered by intramuscular injection.  Vaxart’s oral vaccine pills may change everything.

Our vaccine pills act differently, by attacking invading pathogens in the places where they first enter the body:  the mucosal areas, including the mouth, the nose and the gut.  They are designed to  trigger strong IgA and T-cell responses to repel and overwhelm the invading viral invaders.

Vaxart has begun Phase II trials of its oral vaccine for Covid and for Norovirus– the only company in the world to reach this stage with a COVID-19 vaccine pill.

Company Overview

Headquarters: 290 Utah Avenue South San Francisco, California 94080 United States
Phone number: +1-650-550-****
Website: vaxart.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: VXRT
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2004
Employees: 51-200